je.st
news
Tag: merck
Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors
2015-08-13 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & HOUSTON Clinical Trials to Evaluate Mercks KEYTRUDA (pembrolizumab) in Combination with Other Medicines and Treatments Across Multiple Tumor Types KENILWORTH, N.J. & HOUSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical research collaboration to evaluate Mercks anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel antitumor medicines. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orMerck Investor Relations:Justin Holko, 908-740-1879orMD Anderson Media Relations:Ron Gilmore, 713-745-1898Rlgilmore1@mdanderson.org Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: center
research
solid
cancer
Sigma-Aldrich gets final antitrust approval for Merck merger
2015-08-11 18:44:35| Chemicals - Topix.net
Sigma-Aldrich on Tuesday said it has received approval from Brazil's Council for Economic Defense for its planned $17 billion merger with Germany's Merck KGaA. The St. Louis-based company said it represents the final outstanding approval required for the merger, announced in September 2014.
Tags: final
approval
merger
merck
K-State, Merck release animal handling videos
2015-08-08 14:28:58| Beef
As the benefits to both the animal and the rancher of low-stress cattle handling become more and more evident, the practice is gaining wider acceptance and usage. read more
Tags: videos
release
animal
handling
Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors
2015-07-28 22:15:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Pamela J. Craig, retired chief financial officer of Accenture, and Dr. Paul B. Rothman, dean of the medical faculty, vice president for medicine of The Johns Hopkins University and chief executive officer of Johns Hopkins Medicine, will join the companys board of directors, effective Sept. 1, 2015. Language: English Contact: MerckMedia Contacts:Lainie Keller, 908-236-5036orInvestor Contacts:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck Tops Street 2Q Forecasts
2015-07-28 14:15:31| Biotech - Topix.net
In this Thursday, Dec. 18, 2014 photo, scientist Christopher Kistler checks on experiments in AMBR250 bio-reactors in a laboratory at the Merck company facilities in Kenilworth, N.J. The bio-reactors allow a large number of experiments to be done in the lab at the same time. Merck reports quarterly financial results on Tuesday, July 28, 2015.
Tags: street
tops
forecasts
merck
Sites : [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] next »